Nakita Putty

Nakita Putty supports the Food and Drug Administration’s Office of Acquisition and Grant Services in executing mission-critical procurement activities that sustain the agency’s regulatory science infrastructure. Responsible for managing complex acquisitions in support of scientific research and analytical capabilities, Putty specializes in securing advanced technical services essential for drug safety evaluation, laboratory operations, and medical device validation. Her work directly enables the FDA’s public health mission by ensuring access to high-precision instrumentation, data analysis tools, and specialized scientific support services required for regulatory decision-making. Putty maintains consistent contracting relationships with key vendors including Tranquil Clinical and Research Consulting Services LLC, Toxicologic Pathology Associates Inc., and Progenics Pharmaceuticals Inc., reflecting a focus on niche scientific and clinical research support. These partnerships emphasize specialized expertise in preclinical testing, toxicology, and regulatory compliance services, indicating a preference for contractors with deep domain knowledge in pharmaceutical and biomedical research. Her procurement approach prioritizes technical proficiency and proven performance in highly regulated environments. While the majority of her acquisitions—83.3%—are conducted without set-asides, Putty demonstrates a meaningful commitment to small business participation, with 16.7% of awards structured as Total Small Business Set-Asides under FAR 19.5. This pattern suggests a balanced strategy that leverages broad market competition while intentionally creating opportunities for qualified small businesses capable of delivering specialized scientific services. Her procurement portfolio is exclusively aligned with NAICS 541519 (Other Computer Related Services), underscoring a focus on informatics, data management, computational modeling, and software-enabled analytical platforms that support FDA’s regulatory science initiatives. Putty’s expertise lies in acquiring technology-integrated research services that enhance the agency’s capacity to analyze complex biological and chemical data, ensuring scientific rigor and operational efficiency in public health oversight.